Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NICE | GRAL |
|---|---|---|
| Price | $115.83 | $154.08 |
| Change today | ▲ 1.69% | ▲ 7.55% |
| Market cap | $6.88B | $6.88B |
| Return, 3 months | +17.4% | +124.0% |
| Return, year to date | +2.5% | +80.0% |
| Return, 1 year | -16.1% | +149.7% |
| P/E (TTM) | 16.9 | -15.9 |
| P/B | 1.8 | 2.7 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 60 | 85 |
| 30-day volatility | 50.8% | 103.9% |
| Max drawdown, 1 year | -45.4% | -62.9% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
